|
🐜
|
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
34 auth.
G. Raghu,
M. Rémy-Jardin,
J. Myers,
L. Richeldi,
C. Ryerson,
D. Lederer,
J. Behr,
V. Cottin,
S. Danoff,
F. Morell,
K. Flaherty,
A. Wells,
F. Martinez,
A. Azuma,
T. Bice,
...
Demosthenes Bouros,
K. Brown,
H. Collard,
A. Duggal,
L. Galvin,
Y. Inoue,
R. Jenkins,
T. Johkoh,
E. Kazerooni,
M. Kitaichi,
S. Knight,
G. Mansour,
A. Nicholson,
S. Pipavath,
I. Buendía-Roldán,
M. Selman,
W. Travis,
S. Walsh,
K. Wilson
|
11 |
2018 |
11
🐜
|
|
🐜
|
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
14 auth.
J. Alder,
Julian J‐L Chen,
L. Lancaster,
S. Danoff,
Shu-Chih Su,
J. Cogan,
I. Vulto,
Mingyi Xie,
Xiaodong Qi,
R. Tuder,
...
J. Phillips,
P. Lansdorp,
J. Loyd,
M. Armanios
|
9 |
2008 |
9
🐜
|
|
🐜
|
Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline
43 auth.
G. Raghu,
Society Document,
M. Rémy-Jardin,
C. Ryerson,
J. Myers,
M. Kreuter,
M. Vašáková,
E. Bargagli,
Jonathan H. Chung,
B. Collins,
E. Bendstrup,
H. Chami,
A. Chua,
T. Corte,
J. Dalphin,
...
S. Danoff,
J. Diaz-Mendoza,
A. Duggal,
R. Egashira,
Thomas J. Ewing,
M. Gulati,
Y. Inoue,
A. Jenkins,
K. Johannson,
T. Johkoh,
M. Tamae-Kakazu,
M. Kitaichi,
S. Knight,
D. Koschel,
D. Lederer,
Y. Mageto,
L. Maier,
C. Matiz,
F. Morell,
A. Nicholson,
S. Patolia,
C. Pereira,
E. Renzoni,
M. Salisbury,
M. Selman,
S. Walsh,
W. Wuyts,
K. Wilson
|
9 |
2020 |
9
🐜
|
|
🐢
|
Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?
G. Connors,
L. Christopher‐Stine,
C. Oddis,
S. Danoff
|
8 |
2010 |
8
🐢
|
|
🐜
|
Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors
21 auth.
K. Suresh,
K. R. Voong,
B. Shankar,
P. Forde,
D. Ettinger,
K. Marrone,
R. Kelly,
C. Hann,
B. Levy,
J. Feliciano,
...
J. Brahmer,
D. Feller-Kopman,
A. Lerner,
Hans J Lee,
L. Yarmus,
F. D’Alessio,
R. Hales,
C. Lin,
K. Psoter,
S. Danoff,
J. Naidoo
|
8 |
2018 |
8
🐜
|
|
🐬
|
Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium.
S. Supattapone,
S. Danoff,
A. Theibert,
Suresh K. JOSEPHt,
Joseph STEINERt,
S. Snyder
|
8 |
1988 |
8
🐬
|
|
🐢
|
Management of interstitial lung disease associated with connective tissue disease
S. Mathai,
S. Danoff
|
8 |
2016 |
8
🐢
|
|
🐢
|
Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities.
K. Suresh,
J. Naidoo,
C. Lin,
S. Danoff
|
8 |
2018 |
8
🐢
|
|
🐜
|
Anti–Melanoma Differentiation–Associated Protein 5–Associated Dermatomyositis: Expanding the Clinical Spectrum
7 auth.
John C. Hall,
L. Casciola-Rosen,
L. Samedy,
J. Werner,
Kristie Owoyemi,
S. Danoff,
...
L. Christopher‐Stine
|
8 |
2013 |
8
🐜
|
|
🐬
|
Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues.
C. Ross,
S. Danoff,
M. Schell,
S. Snyder,
A. Ullrich
|
7 |
1992 |
7
🐬
|
|
🦁
|
Inositol 1,4,5-trisphosphate receptors: distinct neuronal and nonneuronal forms derived by alternative splicing differ in phosphorylation.
8 auth.
S. Danoff,
C. D. Ferris,
Cornelia Donath,
Gabriela A. Fischer,
Susan Munemitsu,
Axel Ullrich,
...
Solomon H. Snyder,
Christopher A. Ross
|
7 |
1991 |
7
🦁
|
|
🐢
|
A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies
10 auth.
I. Pinal-Fernandez,
M. Casal-Dominguez,
Julio A. Huapaya,
J. Albayda,
Julie J. Paik,
Cheilonda Johnson,
...
L. Silhan,
L. Christopher‐Stine,
A. Mammen,
S. Danoff
|
7 |
2017 |
7
🐢
|
